Acrivon Therapeutics, Inc. Common Stock / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€520.41K - Gross profit
-€258.91K - SG&A expenses
€21.85M - R&D expenses
€59.37M - EBITDA
-€81.00M - D&A
€779.32K - EBIT
-€81.47M - Interest expenses
€0.00 - EBT
-€74.18M - Tax expenses
-€155.97K - Net income
-€74.18M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€1.18M - Changes in working capital
€3.74M - Operating cash flow
-€61.13M - Capex
€2.04M - Other investing cash flow
€0.00 - Net investing cash flow
€59.63M - Total cash dividends paid
€0.00 - Issuance of common stock
-€46.48M - Debt repayment
€0.00 - Other financing cash flow
-€1.97M - Net financing cash flow
-€2.24M - Foreign exchange effects
€0.00 - Net change in cash
-€3.37M - Cash at end of period
€36.33M - Free cash flow
-€59.08M
Balance sheet
- Cash and cash equivalents
€36.16M - Cash and short-term investments
€118.60M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€853.54K - Total current assets
€119.45M - Property, plant & equipment
€7.01M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€8.80M - Other non-current assets
€1.59M - Total non-current assets
€17.41M - Total assets
€136.86M - Accounts payable
€1.00M - Short-term debt
€1.98M - Other current liabilities
€8.61M - Total current liabilities
€11.59M - Long-term debt
€3.65M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€1.83M - Total liabilities
€13.42M - Common stock
€26.75K - Retained earnings
-€205.11M - Other equity
€91.48K - Total equity
€123.45M - Total liabilities and shareholders' equity
€136.86M
Company information
- Market capitalization
€32.09M - Employees
75 - Enterprise Value
€4.18M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-60.1% Much better than peer group: -313.4% - ROA
-
-54.2% Much better than peer group: -137.6% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-196.8% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€989.13K